Big Moving Stock chart patterns and volume.

Nasdaq: GOOG NFLX BIIB AMZN TSLA ILMN ALXN AMGN COST GMCR CELG FFIV AAPL MDVN WDC Z GILD BMRN ROST
Nyse: ACT V AGN IVV PCP LMT GS FDX MMM PXD IBM NOC TWC CMI APD ANTM GD BA TMO PX
New Highs: NOC BA HAR VAR TSCO KRC NOW EA BR HLS TSS HOLX OPK

The Hot Industries

Medical Appliances & Equipment 3
Multimedia & Graphics Software 1
Information & Delivery Services 1

The Hot Sectors

Healthcare 4
Technology 3
Industrial Goods 2

Social Buzz

OSIR is headed higher?

OSIR Stock ChartSimilar Stocks: VCEL MBLT HSGX BONE IART BHRT JNJ


OSIR
Analyze

Sector:

Healthcare
Daily

Industry:

Biotechnology
Weekly

Employees:

N/A
Monthly

Website:

http://www.osiristx.com

OSIR Osiris Therapeutics, Inc.

Osiris Therapeutics, Inc., a stem cell company, focuses on the development and marketing of therapeutic products to treat medical conditions in the inflammatory, cardiovascular, orthopedic, and wound healing markets. It operates in two segments, Biosurgery and Therapeutics. The Biosurgery segment develops, manufactures, and distributes biologic products for orthopedic, wound healing, and surgical procedures by harnessing the ability of cells and novel constructs for the body's natural healing. It offers Grafix for application to acute and chronic wounds, including diabetic foot ulcers and burns; and Ovation for use in surgical applications. This segment markets and distributes its products directly to hospitals and clinics, as well as through a network of distributors. The Therapeutics segment develops and markets products to treat medical conditions in the inflammatory and cardiovascular disease areas. It offers Prochymal for the treatment of refractory acute graft versus host disease in children. This segment also develops biologic stem cell drug candidates, such as Prochymal that is in clinical trials for various indications, including acute graft versus host disease in pediatric and adult patients, Crohn's disease, and acute myocardial infarction; and Chondrogen for osteoarthritis and cartilage protection. The company has a collaborative agreement with Juvenile Diabetes Research Foundation for the development of Prochymal as a treatment for the preservation of insulin production in patients with newly diagnosed type 1 diabetes mellitus. Osiris Therapeutics, Inc. was founded in 1992 and is headquartered in Columbia, Maryland.

favicon

Osiris Therapeutics, Ocwen Financial, O'Reilly Automotive, Advance Auto Parts and Douglas Dynamics highlighted as ...

15 Jan 2015, 7:30 amOsiris Therapeutics, Ocwen Financial, O'Reilly Automotive, Advance Auto Parts and Douglas Dynamics highlighted as Zacks Bull and Bear of the Day
favicon

Osiris Therapeutics (OSIR) Shares March Higher, Can It Continue? - Tale of the Tape

31 Dec 2014, 6:48 amOsiris Therapeutics (OSIR) Shares March Higher, Can It Continue?